The Paris-based biotech said they changed the study's protocol to ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
News
- Updated: FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
- One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new ...
Operating as the only biotech in the space since, they've landed big-money partnerships with Bayer and Merck, more venture cash and a couple more ...
- Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him
Faheem Hasnain is going back to running a biotech startup. And he ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- Laura Shawver is about to join a lineup of biotech CEOs enjoying overnight fortunes, courtesy of ...
Laura Shawver capped 2019 with an $88 million windfall from the sale of Synthorx to Sanofi. And she pivoted right back into the sweet spot in 2020.
- News briefing: FDA requests new trial for Reata's Friedreich's ataxia program; J&J's Tremfya picks ...
Reata $RETA shares took a nosedive Wednesday after the biotech ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.